Financials

  • Market Capitalization 107.2 M
  • Employee 73
  • Founded 1982
  • CEO Michael F Brigham
  • Website www.immucell.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLQ5Q2
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-51.25
市销率
2.01

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3968
KLRS
Kalaris Therapeutics, Inc. - Common Stock
4.38 USD-0.90%-4.99%-3.52%-57.18%104.21 M USD
3976
ANIX
Anixa Biosciences, Inc. - Common Stock
3.18 USD+3.92%+7.43%+23.74%-1.24%108.19 M USD
3991
VRCA
Verrica Pharmaceuticals Inc. - Common Stock
5.96 USD+0.68%-3.40%+2.76%-1.00%102.39 M USD
3995
INO
Inovio Pharmaceuticals, Inc. - Common Stock
1.21 USD+4.31%+3.42%+8.04%-11.68%99.55 M USD

新闻